Symbol Lookup

Tuesday September 01, 2015 6:14 PM ET. Data delayed 15 minutes.
1.14
0.04 (3.64%)
Bid/Lots
1.05/20
Ask/Lots
2.25/100
Open/Prev Close
1.10/1.10
Day Range
1.08-1.17
52-Week Range
1.03-2.16
Vol/Avg Daily Vol
19.1K/33.4K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
CombiMatrix CombiSNP Array For Prenatal Diagnosis Test Gets New York State Approval
7:25AM ET on Tuesday Aug 18, 2015 by MT Newswires
07:25 AM EDT, 08/18/2015 (MT Newswires) -- CombiMatrix (CBMX) said its SNP-based chromosomal microarray analysis test for prenatal diagnosis, the CombiSNP Array for Prenatal Diagnosis, has received approval from the New York Department of Health....
CombiMatrix's CombiSNP Array for Prenatal Diagnosis Test Granted Approval From New York State Department of Health
7:00AM ET on Tuesday Aug 18, 2015 by GlobeNewswire

CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation genetic screening services, today announced its SNP-based ...

CombiMatrix Corporation Reports Second Quarter 2015 Financial and Operating Results
4:05PM ET on Wednesday Aug 05, 2015 by GlobeNewswire

Marks 7th Consecutive Quarter of Record Prenatal Microarray Test Revenues and Volumes

Conference Call Begins Today at 4:30 p.m. Eastern Time

CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DN...

Company Information

CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc. located in Irvine, California. The Company operates as a diagnostics reference laboratory, providing DNA-based clinical diagnostic testing services to physicians, hospitals, clinics and other laboratories in the areas of pre-and postnatal development disorders and hematology/oncology genomics. The Company's oligo arrays allow the Company to perform aCGH on a much more refined scale than is possible with BAC technology.

CONTACT INFORMATION

Headquarters310 Goddard Ste 150
IRVINE, CA, United States 92618-4617
Phone949-753-0624
Fax949-753-4725

EXECUTIVE OFFICERS

Chairman of the Board, President, Chief Executive OfficerRobert Jessup
DirectorMark McDonough
Chief Financial Officer, Treasurer, SecretaryScott Burell
Independent DirectorScott Gottlieb
Independent DirectorRobert Hoffman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$13.9MBeta-0.05
Revenue (TTM)$9.2MEPS$-0.73
Shares Out.12.7MBook Value$0.64
Dividend Yield0.00%P/E--
Annual Dividend Rate0.00 USDPrice/Sales (TTM)1.5
Ex-Div Date1/1/01P/Cash Flow (TTM)--
Pay Date1/1/01Operating Margin-81.09%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample